161 related articles for article (PubMed ID: 9466480)
1. Assessment of minimal residual disease in patients with acute leukemia.
Baer MR
Curr Opin Oncol; 1998 Jan; 10(1):17-22. PubMed ID: 9466480
[TBL] [Abstract][Full Text] [Related]
2. Monitoring minimal residual disease in acute leukemia: expectations, possibilities and initial clinical results.
Campana D
Int J Clin Lab Res; 1994; 24(3):132-8. PubMed ID: 7819592
[TBL] [Abstract][Full Text] [Related]
3. Combined cell sorting and FISH for detection of minimal residual disease in bone marrow of children with acute leukemia or solid tumors.
Sainati L; Spinelli M; Leszl A; Cocito MG; Stella M; Basso G
Eur J Histochem; 1997; 41 Suppl 2():167-8. PubMed ID: 9859833
[No Abstract] [Full Text] [Related]
4. [Minimal residual disease. Methodologies and clinical implications].
Ortega M; Coll MD; Solé F; Caballín MR
Sangre (Barc); 1999 Aug; 44(4):283-90. PubMed ID: 10589280
[No Abstract] [Full Text] [Related]
5. Detection of minimal residual disease.
Deptala A; Mayer SP
Methods Cell Biol; 2001; 64():385-420. PubMed ID: 11070849
[No Abstract] [Full Text] [Related]
6. Minimal residual disease testing of acute leukemia by flow cytometry immunophenotyping: a retrospective comparison of detection rates with flow cytometry DNA ploidy or FISH-based methods.
Zwick D; Cooley L; Hetherington M
Lab Hematol; 2006; 12(2):75-81. PubMed ID: 16751134
[TBL] [Abstract][Full Text] [Related]
7. How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet.
Béné MC; Kaeda JS
Haematologica; 2009 Aug; 94(8):1135-50. PubMed ID: 19586938
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of minimal residual disease in autologous bone marrow transplantation].
Jørgensen H; Bukh A; Hokland P; Ellegaard J; Madsen PS; Hokland M
Nord Med; 1996 Dec; 111(10):344-7. PubMed ID: 8992466
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease in hematologic malignancies.
San-Miguel JF; Bartram C; Campana D; Andreeff M
Rev Invest Clin; 1994 Apr; Suppl():147-52. PubMed ID: 7886299
[No Abstract] [Full Text] [Related]
10. Minimal residual disease studies in acute leukemia.
Campana D
Am J Clin Pathol; 2004 Dec; 122 Suppl():S47-57. PubMed ID: 15690642
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of minimal residual disease in acute myeloid leukemia.
Buccisano F; Maurillo L; Spagnoli A; Del Principe MI; Ceresoli E; Lo Coco F; Arcese W; Amadori S; Venditti A
Curr Opin Oncol; 2009 Nov; 21(6):582-8. PubMed ID: 19667983
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Multiparameter Flow Cytometry Immunophenotypic Analysis and Quantitative RT-PCR for the Detection of Minimal Residual Disease of Core Binding Factor Acute Myeloid Leukemia.
Ouyang J; Goswami M; Peng J; Zuo Z; Daver N; Borthakur G; Tang G; Medeiros LJ; Jorgensen JL; Ravandi F; Wang SA
Am J Clin Pathol; 2016 Jun; 145(6):769-77. PubMed ID: 27298396
[TBL] [Abstract][Full Text] [Related]
13. [Detection of MRD and its clinical application--review].
Zhu YM; Chen SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1131-6. PubMed ID: 16403298
[TBL] [Abstract][Full Text] [Related]
14. [Detection of minimal residual disease in children leukemia patients by using PCR - review].
He YY; Ye TZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):652-6. PubMed ID: 17605887
[TBL] [Abstract][Full Text] [Related]
15. [Research progress on minimal residual disease in acute leukemia detected by multiparametric flow cytometry].
Jing H; Feng R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):847-51. PubMed ID: 24989307
[TBL] [Abstract][Full Text] [Related]
16. Detection of minimal residual disease in acute myelogenous leukemia.
Sievers EL; Loken MR
J Pediatr Hematol Oncol; 1995 May; 17(2):123-33. PubMed ID: 7749761
[TBL] [Abstract][Full Text] [Related]
17. [Id4 gene methylation for detection of minimal residual disease in acute leukemia].
Zhao Y; Yu L; Wang QS; Li HH; Bo J; Wang SH; Jin HJ; Lou FD
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):298-301. PubMed ID: 16875575
[TBL] [Abstract][Full Text] [Related]
18. [Measurement of minimal residual disease and its implication].
Tsurusawa M; Hori T
Nihon Rinsho; 2012 Apr; 70 Suppl 2():731-6. PubMed ID: 23134035
[No Abstract] [Full Text] [Related]
19. Investigation of minimal residual disease in adult Ph1 positive acute lymphoblastic leukemia by a combination of cell sorting and fluorescence in situ hybridization: a preliminary study on 6 cases.
Cambier N; Soenen-Cornu V; Laï JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 2000 Jun; 85(6):664-5. PubMed ID: 10870127
[No Abstract] [Full Text] [Related]
20. Biphenotypic acute leukemia with t(15;17).
Scolnik MP; Aranguren PN; Cuello MT; Palacios MF; Sanjurjo J; Giunta M; Bracco MM; Acevedo S
Leuk Lymphoma; 2005 Apr; 46(4):607-10. PubMed ID: 16019491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
